The briefing
A stratified analysis from a large international randomized trial suggests that uncontrolled, modifiable cardiovascular risk factors can identify prostate cancer patients who may benefit from added cardiac care. The findings, published in JACC: CardioOncology and presented at ESC Congress 2026, point to targeted interventions for a higher‑risk subgroup.
Original headline
Prostate Cancer Cardiovascular Risk Factors May Help Identify Patients Who Would Benefit From Additional Cardiac Care